Skip to content
Lawmakers introduced the Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act) on September 18, a bill the Biotechnology Innovation Organization (BIO) said […]
ORPHAN Cures Act introduced to boost new rare disease drug development Read More »
Within the challenging field of protein misfolding research, there is a company with a unique and competitive edge that is turning heads and making
BIO’s Emerging Start-Up Stadium winner: Paradox Immunotherapeutics Read More »
Out of the University of Miami, the industry’s first investigator-initiated emergency trial treating a pregnant mother has been authorized by the U.S. Food and
BIO’s Seed-Stage Start-Up Stadium winner: PriZm Therapeutics Read More »
The Inflation Reduction Act (IRA) includes a misguided plan to control prices that will only result in costlier medicine and reduced access, lawmakers and
Why drug price controls ‘risk the future of investment’ in R&D Read More »
September 15 marks the start of Hispanic Heritage Month, an annual reminder and chance to honor the countless contributions made by members of the
In an effort to speed drug development, the Food and Drug Administration (FDA) often allows the use of biomarkers to help prove whether new
Explainer: What are biomarkers? Read More »
New rules for applying for federal SBIR/STTR seed funding will be explained by members of the NIH office reviewing applications in a Sept. 19
BIO webinar offers expert advice on applications for SBIR/STTR grants Read More »
People six months and older should have one of the updated COVID-19 vaccines released by Pfizer-BioNTech and Moderna, under the recommendation approved Sept. 12
CDC recommends everyone get the updated COVID-19 vaccines Read More »
The U.S. Food and Drug Administration (FDA) on Sept. 11 approved updated Pfizer-BioNTech and Moderna vaccines for people over 12. In addition, FDA authorized
FDA approves updated COVID vaccines Read More »
Kintara Therapeutics, Biotechnology Innovation Organization (BIO) member, is an innovative, patient-centered biotech company that is working to change the game when it comes to
Kintara Q&A: novel treatments for aggressive cancers Read More »
